Clonal relatedness between lobular carcinoma in situ and synchronous malignant lesions

Breast Cancer Research

Volumn 14, Issue 4, 2012, Pages

  Andrade, Victor P ^a   Ostrovnaya, Irina ^b   Seshan, Venkatraman E ^b   Morrogh, Mary ^b   Giri, Dilip ^b   Olvera, Narciso ^b   De Brot, Marina ^b   Morrow, Monica ^b   Begg, Colin B ^b   King, Tari A ^b  

^a A C CAMARGO CANCER CENTER   (Brazil)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; TUMOR MARKER;

ARTICLE; BREAST CARCINOMA; CANCER INVASION; CONTROLLED STUDY; COPY NUMBER VARIATION; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; LOBULAR CARCINOMA IN SITU; MAJOR CLINICAL STUDY; MASTECTOMY; MICRODISSECTION; PHENOTYPE; ALLELE; BREAST TUMOR; CANCER GRADING; CARCINOMA IN SITU; CLONAL EVOLUTION; FEMALE; GENETIC ASSOCIATION; GENETICS; LUNG CARCINOMA; METABOLISM; PAGET NIPPLE DISEASE; PATHOLOGY; TUMOR INVASION;

ALLELES; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CLONAL EVOLUTION; DNA COPY NUMBER VARIATIONS; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; NEOPLASM GRADING; NEOPLASM INVASIVENESS; TUMOR MARKERS, BIOLOGICAL;

EID: 84863524370     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr3222     Document Type: Article

References (45)

1. Foote FW, Stewart FW. Lobular carcinoma in situ: a rare form of mammary cancer. Am J Pathol 1941, 17:491-496. 1965212, 19970575.
2. Haagensen CD, Bodian C, Haagensen DE. Lobular neoplasia (lobular carcinoma in situ). Breast Carcinoma. Risk and Detection 1981, 238. Philadelphia: WB Saunders, Haagenson CD.
3. Haagensen CD, Lane N, Lattes R, Bodian C. Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer 1978, 42:737-769. 10.1002/1097-0142(197808)42:2<737::AID-CNCR2820420247>3.0.CO;2-T, 209887.
4. Rosen PP, Kosloff C, Lieberman PH, Adair F, Braun DW. Lobular carcinoma in situ of the breast. Detailed analysis of 99 patients with average follow-up of 24 years. Am J Surg Pathol 1978, 2:225-251. 10.1097/00000478-197809000-00001, 210682.
5. Rosen PP, Senie R, Schottenfeld D, Ashikari R. Noninvasive breast carcinoma: frequency of unsuspected invasion and implications for treatment. Ann Surg 1979, 189:377-382. 10.1097/00000658-197903000-00021, 1397090, 218506.
6. Aulmann S, Penzel R, Longerich T, Funke B, Schirmacher P, Sinn HP. Clonality of lobular carcinoma in situ (LCIS) and metachronous invasive breast cancer. Breast Cancer Res Treat 2008, 107:331-335. 10.1007/s10549-007-9557-0, 17380381.
7. Hwang ES, Nyante SJ, Yi Chen Y, Moore D, DeVries S, Korkola JE, Esserman LJ, Waldman FM. Clonality of lobular carcinoma in situ and synchronous invasive lobular carcinoma. Cancer 2004, 100:2562-2572. 10.1002/cncr.20273, 15197797.
8. Mastracci TL, Shadeo A, Colby SM, Tuck AB, O'Malley FP, Bull SB, Lam WL, Andrulis IL. Genomic alterations in lobular neoplasia: a microarray comparative genomic hybridization signature for early neoplastic proliferationin the breast. Genes Chromosomes Cancer 2006, 45:1007-1017. 10.1002/gcc.20368, 16897748.
9. Buerger H, Otterbach F, Simon R, Schafer KL, Poremba C, Diallo R, Brinkschmidt C, Dockhorn-Dworniczak B, Boecker W. Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes. J Pathol 1999, 189:521-526. 10.1002/(SICI)1096-9896(199912)189:4<521::AID-PATH472>3.0.CO;2-B, 10629552.
10. Lu YJ, Osin P, Lakhani SR, Di Palma S, Gusterson BA, Shipley JM. Comparative genomic hybridization analysis of lobular carcinoma in situ and atypical lobular hyperplasia and potential roles for gains and losses of genetic material in breast neoplasia. Cancer Res 1998, 58:4721-4727.
11. Nishizaki T, Chew K, Chu L, Isola J, Kallioniemi A, Weidner N, Waldman FM. Genetic alterations in lobular breast cancer by comparative genomic hybridization. Int J Cancer 1997, 74:513-517. 10.1002/(SICI)1097-0215(19971021)74:5<513::AID-IJC6>3.0.CO;2-6, 9355973.
12. Vos CB, Cleton-Jansen AM, Berx G, de Leeuw WJ, ter Haar NT, van Roy F, Cornelisse CJ, Peterse JL, van de Vijver MJ. E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis. Br J Cancer 1997, 76:1131-1133. 10.1038/bjc.1997.523, 2228132, 9365159.
13. Reis-Filho JS, Simpson PT, Gale T, Lakhani SR. The molecular genetics of breast cancer: the contribution of comparative genomic hybridization. Pathol Res Pract 2005, 201:713-725.
14. Morrogh M, Olvera N, Bogomolniy F, Borgen PI, King TA. Tissue preparation for laser capture microdissection and RNA extraction from fresh frozen breast tissue. Biotechniques 2007, 43:41-42. 44 and 46 passim, 10.2144/000112497, 17695251.
15. Fitzgibbons PL, Austin RM. Expert review of histologic slides and Papanicolaou tests in the context of litigation or potential litigation. Surgical Pathology Committee and Cytopathology Committee of the College of American Pathologists. Arch Pathol Lab Med 2000, 124:1717-1719.
16. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991, 19:403-410. 10.1111/j.1365-2559.1991.tb00229.x, 1757079.
17. Silverstein MJ, Poller DN, Waisman JR, Colburn WJ, Barth A, Gierson ED, Lewinsky B, Gamagami P, Slamon DJ. Prognostic classification of breast ductal carcinoma-in-situ. Lancet 1995, 345:1154-1157. 10.1016/S0140-6736(95)90982-6, 7723550.
18. Sneige N, Wang J, Baker BA, Krishnamurthy S, Middleton LP. Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: a report of 24 cases. Mod Pathol 2002, 15:1044-1050. 10.1097/01.MP.0000030450.20581.E3, 12379750.
19. Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, Dowsett M, Fitzgibbons PL, Hanna WM, Langer A, McShane LM, Paik S, Pegram MD, Perez EA, Press MF, Rhodes A, Sturgeon C, Taube SE, Tubbs R, Vance GH, van de Vijver M, Wheeler TM, Hayes DF. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. Arch Pathol Lab Med 2007, 131:18-43.
20. Venkatraman ES, Olshen AB. A faster circular binary segmentation algorithm for the analysis of array CGH data. Bioinformatics 2007, 23:657-663. 10.1093/bioinformatics/btl646, 17234643.
21. Ostrovnaya I, Olshen AB, Seshan VE, Orlow I, Albertson DG, Begg CB. A metastasis or a second independent cancer? Evaluating the clonal origin of tumors using array copy number data. Stat Med 2010, 29:1608-1621. 3145177, 20205270.
22. Database of Genomic Variants. , http://projects.tcag.ca/variation/
23. Ostrovnaya I, Seshan VE, Olshen A, Begg CB. Clonality: an R package for testing clonal relatedness of two tumors from the same patient based on their genomic profiles. Bioinformatics 2011, 27:1698-1699. 10.1093/bioinformatics/btr267, 3106202, 21546399.
24. Page DL, Kidd TE, Dupont WD, Simpson JF, Rogers LW. Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol 1991, 22:1232-1239. 10.1016/0046-8177(91)90105-X, 1748429.
25. Bratthauer GL, Tavassoli FA. Lobular intraepithelial neoplasia: previously unexplored aspects assessed in 775 cases and their clinical implications. Virchows Arch 2002, 440:134-138. 10.1007/s00428-001-0541-5, 11964042.
26. Lopez-Garcia MA, Geyer FC, Lacroix-Triki M, Marchio C, Reis-Filho JS. Breast cancer precursors revisited: molecular features and progression pathways. Histopathology 2010, 57:171-192. 10.1111/j.1365-2559.2010.03568.x, 20500230.
27. Wagner PL, Kitabayashi N, Chen YT, Shin SJ. Clonal relationship between closely approximated low-grade ductal and lobular lesions in the breast: a molecular study of 10 cases. Am J Clin Pathol 2009, 132:871-876. 10.1309/AJCP7AK1VWFNMCSW, 19926578.
28. Morandi L, Marucci G, Foschini MP, Cattani MG, Pession A, Riva C, Eusebi V. Genetic similarities and differences between lobular in situ neoplasia (LN) and invasive lobular carcinoma of the breast. Virchows Arch 2006, 449:14-23. 10.1007/s00428-006-0192-7, 16612623.
29. King TA, Sakr RA, Muhsen S, Andrade VP, Giri D, Van Zee KJ, Morrow M. Is there a low-grade precursor pathway in breast cancer?. Ann Surg Oncol 2012, 19:1115-1121. 10.1245/s10434-011-2053-0, 21935747.
30. Acs G, Lawton TJ, Rebbeck TR, LiVolsi VA, Zhang PJ. Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications. Am J Clin Pathol 2001, 115:85-98. 10.1309/FDHX-L92R-BATQ-2GE0, 11190811.
31. Choi YJ, Pinto MM, Hao L, Riba AK. Interobserver variability and aberrant E-cadherin immunostaining of lobular neoplasia and infiltrating lobular carcinoma. Mod Pathol 2008, 21:1224-1237. 10.1038/modpathol.2008.106, 18587329.
32. Da Silva L, Parry S, Reid L, Keith P, Waddell N, Kossai M, Clarke C, Lakhani SR, Simpson PT. Aberrant expression of E-cadherin in lobular carcinomas of the breast. Am J Surg Pathol 2008, 32:773-783. 10.1097/PAS.0b013e318158d6c5, 18379416.
33. Harigopal M, Shin SJ, Murray MP, Tickoo SK, Brogi E, Rosen PP. Aberrant E-cadherin staining patterns in invasive mammary carcinoma. World J Surg Oncol 2005, 3:73. 10.1186/1477-7819-3-73, 1308872, 16287501.
34. Jacobs TW, Pliss N, Kouria G, Schnitt SJ. Carcinomas in situ of the breast with indeterminate features: role of E-cadherin staining in categorization. Am J Surg Pathol 2001, 25:229-236. 10.1097/00000478-200102000-00011, 11176072.
35. Moriya T, Kozuka Y, Kanomata N, Tse GM, Tan PH. The role of immunohistochemistry in the differential diagnosis of breast lesions. Pathology 2009, 41:68-76.
36. Allred DC, Wu Y, Mao S, Nagtegaal ID, Lee S, Perou CM, Mohsin SK, O'Connell P, Tsimelzon A, Medina D. Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution. Clin Cancer Res 2008, 14:370-378. 10.1158/1078-0432.CCR-07-1127, 18223211.
37. Simpson PT, Reis-Filho JS, Gale T, Lakhani SR. Molecular evolution of breast cancer. J Pathol 2005, 205:248-254. 10.1002/path.1691, 15641021.
38. Xing M. BRAF mutation in thyroid cancer. Endocr Relat Cancer 2005, 12:245-262. 10.1677/erc.1.0978, 15947100.
39. Berx G, Cleton-Jansen AM, Strumane K, de Leeuw WJ, Nollet F, van Roy F, Cornelisse C. E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene 1996, 13:1919-1925.
40. De Leeuw WJ, Berx G, Vos CB, Peterse JL, Van de Vijver MJ, Litvinov S, Van Roy F, Cornelisse CJ, Cleton-Jansen AM. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. J Pathol 1997, 183:404-411. 10.1002/(SICI)1096-9896(199712)183:4<404::AID-PATH1148>3.0.CO;2-9, 9496256.
41. Droufakou S, Deshmane V, Roylance R, Hanby A, Tomlinson I, Hart IR. Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast. Int J Cancer 2001, 92:404-408. 10.1002/ijc.1208, 11291078.
42. Rieger-Christ KM, Pezza JA, Dugan JM, Braasch JW, Hughes KS, Summerhayes IC. Disparate E-cadherin mutations in LCIS and associated invasive breast carcinomas. Mol Pathol 2001, 54:91-97. 10.1136/mp.54.2.91, 1187009, 11322170.
43. Brooks-Wilson AR, Kaurah P, Suriano G, Leach S, Senz J, Grehan N, Butterfield YS, Jeyes J, Schinas J, Bacani J, Kelsey M, Ferreira P, MacGillivray B, MacLeod P, Micek M, Ford J, Foulkes W, Australie K, Greenberg C, LaPointe M, Gilpin C, Nikkel S, Gilchrist D, Hughes R, Jackson CE, Monaghan KG, Oliveira MJ, Seruca R, Gallinger S, Caldas C, et al. Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria. J Med Genet 2004, 41:508-517. 10.1136/jmg.2004.018275, 1735838, 15235021.
44. More H, Humar B, Weber W, Ward R, Christian A, Lintott C, Graziano F, Ruzzo AM, Acosta E, Boman B, Harlan M, Ferreira P, Seruca R, Suriano G, Guilford P. Identification of seven novel germline mutations in the human E-cadherin (CDH1) gene. Hum Mutat 2007, 28:203.
45. Sarrio D, Moreno-Bueno G, Hardisson D, Sanchez-Estevez C, Guo M, Herman JG, Gamallo C, Esteller M, Palacios J. Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression and microsatellite instability. Int J Cancer 2003, 106:208-215. 10.1002/ijc.11197, 12800196.